Headquarters: Gaithersburg, Maryland, United States, North America
Description: Sirnaomics is a clinical-stage biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference (RNAi) technology. The RNAi technology is used to discover and develop novel therapeutics with a focus on oncology, anti-fibrotic therapeutics, and viral infection. Its proprietary Polypeptide Nano-Particle (PNP) technology is used for small interfering RNA (siRNA) drug delivery. This technology allows accessing the tumor micro-environment (TME), as well as various cell types in the liver. Sirnaomics was founded by Patrick Y. Lu and David M. Evans in 2007 and is based in Gaithersburg, Maryland.
TechStackLeads is a B2B go-to-market search engine. We help sales teams find prospect faster with greate accuracy.
Our search engine indexes companies, jobs, blogs, news, and funding events so you can find the right propsects faster. Enter a keyword or phrase below to see results instantly.